Meul, T. ; Berschneider, K. ; Schmitt, S. ; Mayr, C. ; Mattner, L. ; Schiller, H. B. ; Yazgili, A.S. ; Wang, X.* ; Lukas, C. ; Schlesser, C. ; Prehn, C. ; Adamski, J. ; Graf, E. ; Schwarzmayr, T. ; Perocchi, F. ; Kukat, A.* ; Trifunovic, A.* ; Kremer, L.S. ; Prokisch, H. ; Popper, B.* ; von Toerne, C. ; Hauck, S.M. ; Zischka, H. ; Meiners, S.
Mitochondrial regulation of the 26S proteasome.
Cell Rep. 32:108059 (2020)
The proteasome is the main proteolytic system for targeted protein degradation in the cell and is fine-tuned according to cellular needs. Here, we demonstrate that mitochondrial dysfunction and concomitant metabolic reprogramming of the tricarboxylic acid (TCA) cycle reduce the assembly and activity of the 26S proteasome. Both mitochondrial mutations in respiratory complex I and treatment with the anti-diabetic drug metformin impair 26S proteasome activity. Defective 26S assembly is reversible and can be overcome by supplementation of aspartate or pyruvate. This metabolic regulation of 26S activity involves specific regulation of proteasome assembly factors via the mTORC1 pathway. Of note, reducing 26S activity by metformin confers increased resistance toward the proteasome inhibitor bortezomib, which is reversible upon pyruvate supplementation. Our study uncovers unexpected consequences of defective mitochondrial metabolism for proteasomal protein degradation in the cell, which has important pathophysiological and therapeutic implications.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
26s Proteasome ; Aspartate ; Metabolic Reprogramming ; Metformin ; Mitochondria ; Proteasome Assembly Factors ; Proteasome Inhibitor Resistance ; Pyruvate ; Respiratory Complex I ; Rpn6 ; Tca; Complex I Deficiency; Protein-synthesis; Mutations Cause; Cultured-cells; Degradation; Phosphorylation; Diseases; Subunits; Pathway; System
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2020
Prepublished im Jahr
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 32,
Heft: 8,
Seiten: ,
Artikelnummer: 108059
Supplement: ,
Reihe
Verlag
Cell Press
Verlagsort
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30202 - Environmental Health
30203 - Molecular Targets and Therapies
80000 - German Center for Lung Research
30201 - Metabolic Health
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Lung Research
Enabling and Novel Technologies
Genetics and Epidemiology
Helmholtz Diabetes Center
PSP-Element(e)
G-501600-004
G-505200-001
G-501800-810
G-505600-003
G-500700-001
G-502295-001
G-503292-001
G-505700-001
A-630700-001
G-505200-003
Förderungen
Copyright
Erfassungsdatum
2020-09-21